Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
A separate analysis of the SURMOUNT-1 trials first 72 weeks showed that tirzepatide led to lasting blood pressure control among 2,539 non-diabetic overweight/obese adults, leading to 6.8 mm Hg systolic and 4.2 mm Hg diastolic net reductions (mostly occurring in first 24 weeks)
GLP-1 plays a vital role in appetite suppression, regulating food intake, and enhancing feelings of satiety
A doctor can suggest safer options or techniques that fit into your overall treatment
Does insulin resistance point toward one option over the other
US$ 28.09
US$ 24.56
US$ 26.65
US$ 27.28
US$ 25.35
US$ 20.42
